Several billionaires, most of them Californians, have been funding firms involved in developing life-extension technologies. What if they succeed? What if billionaires alive today live indefinitely and get ever richer?
..Larry Ellison has put at least half a billion dollars into biomedical research through the Ellison Medical Foundation and other initiatives, including $200 million in funding to establish the Lawrence J. Ellison Institute for Transformative Medicine at the University of Southern California in Los Angeles.
Regenerative biomedicine investors
..Some of the more recognizable names who have been putting money into such efforts: Larry Ellison (founder of Oracle), Larry Page and Sergey Brin (founders of Google), Jeff Bezos (founder of Amazon), and Peter Thiel, cofounder of PayPal and Palantir Technologies.
Immortality by 2030?
In late February, Diamandis wrote to subscribers of his email bulletin: "I asked the smartest people I know for their tech predictions for the next 20 years (2018 – 2038). What are the breakthroughs we can expect on our countdown to the Singularity?"
One of the predictions he listed was that by 2030, "humanity will have achieved Longevity Escape Velocity for the wealthiest."
..can boost longevity by 50%. It extends the life of 2-year-old mice to three years.
https://www.nextbigfuture.com/2018/08/80-year-old-billionaires-are-injecting-placental-stem-cells-to-boost-lifespan-and-health.html The Global Stem Cells Group is a stand out from many companies in the stem cell medicine arena in that we focus on serving our clients by delivering the most relevant cutting edge solutions. We are committed to balancing competitive pricing and providing solid economic gains for our shareholders. By providing the best cellular medicine services available, we believe that we are building a company that will create more value for our customers and our stockholders.
We pledge to adhere to the highest standards of integrity on behalf of our customers, our stockholders, and the world. We have created the optimal corporate structure to realize Global Stem Cell Group’s long-term potential, and we have established the appropriate financial controls and management oversight of our internal processes.
Laho has been a two month organized run from .0004 to to .0017? I have a hard time believing that this isn’t classic consolation and building higher bases
Market Data 
Markets 
AI
